Skip to content

Vomiting Prevention in Children With Cancer

Pediatric Cancer | Chemotherapy Induced Nausea and Vomiting | Quality of Life (QOL)

The goal of this single arm trial is to learn if a machine learning (ML) model predicting the risk of vomiting within the next 96 hours will impact vomiting outcomes in inpatient cancer pediatric patients.

The main questions it aims to answer are whether an ML model predicting the risk of vomiting within the next 96 hours will:

Primary

1\. Reduce the proportion with any vomiting within the 96-hour window

Secondary

1. Reduce the number of vomiting episodes
2. Increase the proportion receiving care pathway-consistent care
3. Impact on number of administrations and costs of antiemetic medications

Newly admitted participants will have a ML model predict the risk of vomiting within the next 96 hours according to their medical admission information. The prediction will be made at 8:30 AM following admission. Pharmacists will be charged with bringing information about patients' vomiting risk to the attention of the medical team and implementing interventions.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* All pediatric patients admitted to the oncology service at SickKids

Exclusion Criteria:

* Pediatric patients admitted to the oncology service at SickKids that are discharged prior to prediction time

Lieu de l'étude

The Hospital for Sick Children
The Hospital for Sick Children
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Lillian Sung, MD, PhD

[email protected]
416-813-5287
Étude parrainée par
The Hospital for Sick Children
Participants recherchés
Plus d'informations
ID de l'étude: NCT06886451